If buying marijuana legally doesn’t already seem a bit scandalous, then surely the cunning short report about Canadian cannabis company Aphria (APHA) will …

Proteostasis Therapeutics (PTI) announced today a worldwide, exclusive license agreement with Genentech for the rights to a potential new therapy, without revealing what …

It was a short and dramatic plunge for Johnson & Johnson (JNJ). The stock lost over 10% of its value following a Reuters report …

New Age Beverages Corporation (NBEV) announced earlier this month the acquisition of Morinda Holdings for $85 million. Since the takeover, the company’s shares …

Aphria (APHA) is trying to recover from a near $1.1 billion loss in value after a harsh short report came out suggesting the …

Catalyst Pharmaceuticals (CPRX) hosted a conference call yesterday to discuss its commercialization plan for the company’s newly FDA-approved LEMS drug, Firdapse. Catalyst announced …

Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.

Neurocine Biosciences (NBIX) stock dropped about 14% Wednesday after news that its clinical trial for Ingrezza T-Force GOLD, for the treatment of Tourrette …

Following an intense short report alleging Aphria (APHA), a Canadian cannabis company, is scamming its investors, analysts are having second guesses about the …

Bausch Health Companies (BHC) announced today it will acquire some assets of Synergy Pharmaceuticals, which is being called the “stalking horse” agreement – …